Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aryl hydrocarbon receptor (AhR) agonists for the prevention and treatment of inflammatory disorders

Aryl hydrocarbon receptor (AhR) agonists for the prevention and treatment of inflammatory disorders

US Patent 11458141 · Granted Oct 4, 2022

Estimated economic value: $59,729,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, 2025
N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, 2024
Itraconazole analogs and use thereof2024
Imidazole-containing inhibitors of ALK2 kinase2024
Hybrid cyclic libraries and screens thereof2024
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related c2024
Inducing cell death by hyperactivation of motility networks2024
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related c2024
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related c2023
Rapaglutins, novel inhibitors of GLUT and use thereof2023
Imidazole-containing inhibitors of ALK2 kinase2023
N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, 2023